首页> 外文期刊>Immunobiology: Zeitschrift fur Immunitatsforschung >Tim-3 identifies exhausted follicular helper T cells in breast cancer patients
【24h】

Tim-3 identifies exhausted follicular helper T cells in breast cancer patients

机译:Tim-3在乳腺癌患者中鉴定出疲惫的滤泡辅助性T细胞

获取原文
获取原文并翻译 | 示例
       

摘要

Breast cancer is the most common cancer diagnosed in women worldwide. Although a series of treatment options have improved the overall 5-year survival rate to 90%, individual responses still vary from patient to patient. New evidence suggested that the infiltration of CXCL13-expressing CD4(+) follicular helper cells (Tfh) in breast tumor predicted better survival. Here, we examined the regulation of Tfh function in breast cancer patients in depth. We found that the frequencies of circulating Tfh cells were not altered in breast cancer patients compared to healthy controls. However, the expression of PD-1 and Tim-3 in Tfh cells was significantly elevated in breast cancer patients. Interestingly, we observed a preferential upregulation of PD-1 in Tim-3(+) Tfh cells compared to Tim-3(-) Tfh cells. Coexpression of PD-1 and Tim-3 is typically a hallmark of functional exhaustion in chronic virus infections and tumor. To examine whether Tim-3(+) identifies exhausted Tfh cells, we stimulated Tfh cells with anti-CD3/CD28, and found that Tim-3(+) T cells expressed reduced frequencies of chemokine CXCL13 and cytokine interleukin 21 (IL-21), and contained fewer proliferating cells, than Tim-3(-) Tfh cells. Compared to those cocultured with Tim-3(-) Tfh cells, naive B cells cocultured with Tim-3(+) Tfh cells resulted in significantly less IgM, IgG and IgA production after 12 day incubation, demonstrating a reduction in Tim-3(+) Tfh-mediated B cell help. Moreover, the frequencies of Tim-3(+) Tfh cells in resected breast tumor were further upregulated than autologous blood, suggesting a participation of Tim-3(+) Tfh cells in tumor physiology. Overall, the data presented here provided new insight in the regulation of Tfh cells in breast cancer patients. (C) 2016 Elsevier GmbH. All rights reserved.
机译:乳腺癌是全世界女性中最常见的癌症。尽管一系列治疗方案已将整体5年生存率提高到90%,但每个患者的个体反应仍然有所不同。新证据表明,乳腺肿瘤中表达CXCL13的CD4(+)滤泡辅助细胞(Tfh)的浸润预示了更好的生存率。在这里,我们深入研究了乳腺癌患者中Tfh功能的调节。我们发现与健康对照组相比,乳腺癌患者中循环Tfh细胞的频率没有改变。然而,Tfh细胞中PD-1和Tim-3的表达在乳腺癌患者中显着升高。有趣的是,我们发现与Tim-3(-)Tfh细胞相比,Tim-3(+)Tfh细胞中PD-1的优先上调。 PD-1和Tim-3的共表达通常是慢性病毒感染和肿瘤中功能衰竭的标志。为了检查Tim-3(+)是否能识别出疲惫的Tfh细胞,我们用抗CD3 / CD28刺激了Tfh细胞,并发现Tim-3(+)T细胞表达的趋化因子CXCL13和细胞因子白介素21(IL-21)的频率降低。 ),并且所含的增殖细胞少于Tim-3(-)Tfh细胞。与与Tim-3(-)Tfh细胞共培养的细胞相比,与Tim-3(+)Tfh细胞共培养的幼稚B细胞在孵育12天后产生的IgM,IgG和IgA明显减少,这表明Tim-3(-)减少+)Tfh介导的B细胞帮助。此外,切除的乳腺肿瘤中Tim-3(+)Tfh细胞的频率比自体血进一步上调,表明Tim-3(+)Tfh细胞参与肿瘤生理。总体而言,此处提供的数据为乳腺癌患者Tfh细胞的调控提供了新的见识。 (C)2016 Elsevier GmbH。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号